ID   HCC366 BL
AC   CVCL_M077
SY   HCC-366BL; HCC366-BL; HCC366BL; Hamon Cancer Center 366 BL
DR   DSMZ; ACC-895
DR   DSMZCellDive; ACC-895
DR   Wikidata; Q54881709
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Doubling time: ~15-24 hours (DSMZ=ACC-895).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-895
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 19
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 18,20
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 10,15
ST   FGA: 19,21
ST   Penta D: 9
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2059 ! HCC366
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 14
//
RX   PubMed=9559342; DOI=10.1002/(SICI)1098-2264(199804)21:4<308::AID-GCC4>3.0.CO;2-2;
RA   Virmani A.K., Fong K.M., Kodagoda D.R., McIntire D., Hung J., Tonk V.,
RA   Minna J.D., Gazdar A.F.;
RT   "Allelotyping demonstrates common and distinct patterns of chromosomal
RT   loss in human lung cancer types.";
RL   Genes Chromosomes Cancer 21:308-319(1998).
//